KOBAYASHI PHARMACEUTICAL CO.,LTD., headquartered in Osaka, was reported to have caused health damage through red yeast rice-related products in 2024, and Toyoda Kaichi (豊田賀一) became president the year after the issue came to light.
KOBAYASHI PHARMACEUTICAL CO.,LTD., headquartered in Osaka, was reported to have caused health damage in connection with red yeast rice-related products in 2024.
According to media reports, Toyoda Kaichi (豊田賀一) became president and representative director the year after the issue came to light. His name is mentioned in the article.
The article covers both the facts surrounding the pharmaceutical company and changes in its management, and reports that further developments are awaited.